⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AXSM News
Axsome Therapeutics, Inc
Axsome Therapeutics Presents New AUVELITY® Data in Major Depressive Disorder at the American Society of Clinical Psychopharmacology (ASCP) 2026 Annual Meeting
globenewswire.com
AXSM
Axion Semiconductor Acquires Moov Technologies
prnewswire.com
AXSM
Axsome Therapeutics Recognizes Mental Health Month
globenewswire.com
AXSM
Axsome Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
AXSM
Form 8-K
sec.gov
AXSM
Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
AXSM
Axsome Therapeutics Hosts AUVELITY® FDA Approval Investor Event Featuring Expert Thought Leader
globenewswire.com
AXSM
Form 8-K
sec.gov
AXSM
Axsome Therapeutics Announces FDA Approval of AUVELITY® (dextromethorphan HBr and bupropion HCl) for the Treatment of Agitation Associated with Dementia due to Alzheimer’s Disease
globenewswire.com
AXSM
$58.8 Bn LEO Satellite Markets - Global Forecast to 2036 Featuring SpaceX, Amazon (Project Kuiper), OneWeb, Telesat, Axiom Space, Relativity Space, Axiom Space, Planet Labs, Capella Space
globenewswire.com
AMZN
SPCE
AXSM
RVSN
PL